Rohto Pharmaceutical has published the "ROHTO Well-being Report - Integrated Report 2023".
September 12, 2023
ROHTO Pharmaceutical Co., Ltd. (Headquarters: Osaka City, President: Masafumi Sugimoto) has published the Japanese version of the "ROHTO Well-being Report - Rohto Pharmaceutical Integrated Report 2023".
Click here for details
The ROHTO Well-being Report provides a comprehensive overview of financial and non-financial information, including business conditions, performance, corporate governance structure, and environmental and social initiatives, for a wide range of stakeholders, including shareholders and investors.
Our purpose is to lead all individuals and society around us to "Well-being" by delivering "health" to people around the world through our products and services. We conduct our business with this purpose in mind. We will explain the direction we aim to take by 2030, the value we will provide to society to achieve sustainable growth, and our ESG initiatives toward a sustainable society, focusing on the "ROHTO Group Comprehensive Management Vision 2030"
Our group will continue to value communication with all stakeholders and aim to contribute to a sustainable society and achieve healthy group growth.
The English version is scheduled for release in late November.